Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Mesna × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 7 Lymphoma 5 Hematologic Neoplasms 5 Myelodysplastic Syndromes 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Leukemia, B-Cell 3 Hematologic Diseases 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Bone Marrow Diseases 2 Teratoma 1 Sarcoma 1 Recurrence 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Myeloproliferative Disorders 1

Interventions

Specimen Handling 2 Sorafenib 2 Irinotecan 2 poly ICLC 1 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 Watchful Waiting 1 Vincristine 1 Platinum 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡